Antioxidants (Jan 2023)

IL-21, Inflammatory Cytokines and Hyperpolarized CD8<sup>+</sup> T Cells Are Central Players in Lupus Immune Pathology

  • Soumya Sengupta,
  • Gargee Bhattacharya,
  • Subhasmita Mohanty,
  • Shubham K. Shaw,
  • Gajendra M. Jogdand,
  • Rohila Jha,
  • Prakash K. Barik,
  • Jyoti R. Parida,
  • Satish Devadas

DOI
https://doi.org/10.3390/antiox12010181
Journal volume & issue
Vol. 12, no. 1
p. 181

Abstract

Read online

Systemic lupus erythematous (SLE) is a chronic autoimmune disorder, broadly characterized by systemic inflammation along with heterogeneous clinical manifestations, severe morbidity, moribund organ failure and eventual mortality. In our study, SLE patients displayed a higher percentage of activated, inflamed and hyper-polarized CD8+ T cells, dysregulated CD8+ T cell differentiation, significantly elevated serum inflammatory cytokines and higher accumulation of cellular ROS when compared to healthy controls. Importantly, these hyper-inflammatory/hyper-polarized CD8+ T cells responded better to an antioxidant than to an oxidant. Terminally differentiated Tc1 cells also showed plasticity upon oxidant/antioxidant treatment, but that was in contrast to the SLE CD8+ T cell response. Our studies suggest that the differential phenotype and redox response of SLE CD8+ T cells and Tc1 cells could be attributed to their cytokine environs during their respective differentiation and eventual activation environs. The polarization of Tc1 cells with IL-21 drove hyper-cytotoxicity without hyper-polarisation suggesting that the SLE inflammatory cytokine environment could drive the extreme aberrancy in SLE CD8+ T cells.

Keywords